Search

Your search keyword '"Wang N"' showing total 6 results
Start Over Author "Wang N" Language german
6 results on '"Wang N"'

2. Diabetische Retinopathie und geschätzter Hirndruck. Beijing Eye Study 2011

Author

Jonas, JB, Wang, N, Xu, J, Wang, Y, You, Q, Yang, D, Xie, X, and Xu, L

Subjects
ddc: 610, 610 Medical sciences, Medicine
Abstract

Hintergrund: Der cerebrospinale Flüssigkeitsdruck (CSFD) beeinflusst den retinalen Venendruck und daher auch den kapillären retinalen Blutdruck. Wir untersuchten, ob die Häufigkeit und Ausprägungsgrad der diabetischen Retinopathie (DR) vom CSFD abhängt. Methoden: Die epidemiologische[for full text, please go to the a.m. URL], 27. Jahrestagung der Retinologischen Gesellschaft

Published
2014
Full Text
View/download PDF

3. Sofortige versus verzögerte biomechanische Belastung in primären versus passagierten 3-D kultivierten Chondrozyten zu verschiedenen Zeitpunkten während des Bioreaktor Tissue Engineering

Author

Salzmann, GM, Wang, N, Niemeyer, P, Grad, S, Stoddart, M, Alini, M, and Südkamp, NP

Subjects
ddc: 610, 610 Medical sciences, Medicine
Abstract

Fragestellung: In der Verwirklichung von klinischer autologer Chondrozytentransplantation (ACT) besteht bis heute kein Standard was einfache Zellkulturparameter, wie in vitro Zeit oder Passagezahl, angeht. Die Studienlage zeigt, dass diese Parameter jedoch einen signifikanten Einfluss auf die Chondrogenese[for full text, please go to the a.m. URL], Deutscher Kongress für Orthopädie und Unfallchirurgie (DKOU 2012)

Published
2012
Full Text
View/download PDF

5. [Not Available].

Author

Jonas JB, Yang D, and Wang N

Subjects
Humans, Arterial Pressure, Glaucoma complications, Glaucoma pathology, Intraocular Pressure, Optic Nerve Diseases etiology, Optic Nerve Diseases pathology
Published
2014

6. [Effect of metronidazole on phenazone metabolism].

Author

Staiger C, Wang NS, de Vries J, and Weber E

Subjects
Adult, Cimetidine pharmacology, Drug Interactions, Female, Humans, Hydroxylation, Kinetics, Male, Time Factors, Antipyrine metabolism, Metronidazole pharmacology
Abstract

Nine volunteers received in random order on three occasions either 15 mg/kg phenazone (antipyrine; in the following called phenazone, INN), 15 mg/kg phenazone and 1000 mg cimetidine or 15 mg/kg phenazone and 1000 mg metronidazole. Cimetidine prolonged phenazone half-life from 12.7 +/- 1.0 h to 15.5 +/- 1.0 h (p less than 0.05) and decreased total plasma clearance of phenazone from 40.9 +/- 3.9 ml/min to 33.9 +/- 2.9 ml/min (p less than 0.05). When metronidazole was given with phenazone to the volunteers no change of phenazone pharmacokinetics in plasma occurred. Urinary excretion of the main oxidative metabolites of phenazone (4-hydroxyphenazone, 3-hydroxymethylphenazone and norphenazone) was unaffected during cimetidine as well as metronidazole treatment. Both metronidazole and cimetidine potentiate the anticoagulant effect of warfarin. In contrast it could be shown that cimetidine does not interact with the metabolism of phenprocoumon. Whether metronidazole interferes with the pharmacokinetics of phenprocoumon should be studied in further investigations.

Published
1984

Catalog

Books, media, physical & digital resources
See catalog results